ESLA
Income statement / Annual
Last year (2025), Estrella Immunopharma Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Estrella Immunopharma Inc's net income was -$13.06 M.
See Estrella Immunopharma Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
06/30/2024 |
12/31/2022 |
06/30/2022 |
06/30/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.25 M
|
$6.41 M
|
$4.11 M
|
$0.00
|
$1.39 M
|
$457.23 K
|
| General & Administrative Expenses |
$0.00
|
$1.42 M
|
$3.20 M
|
$0.00
|
$296.25 K
|
$276.46 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.81 M
|
$2.44 M
|
$3.20 M
|
$1.37 M
|
$296.25 K
|
$276.46 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$201.31 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.06 M
|
$8.85 M
|
$7.31 M
|
$1.57 M
|
$1.69 M
|
$733.69 K
|
| Cost And Expenses |
$13.06 M
|
$8.85 M
|
$7.31 M
|
$1.57 M
|
$1.69 M
|
$733.69 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$654.07 K
|
$1.43 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
-$39.59 K
|
$0.00
|
$228.49 K
|
$236.56 K
|
$206.30 K
|
| EBITDA |
-$13.06 M |
-$8.85 M |
-$7.31 M |
-$686.97 K |
-$11.16 K |
-$733.69 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$0.00
|
$0.00
|
$654.07 K
|
$1.44 M
|
$0.00
|
| Income Before Tax |
-$13.06 M
|
-$8.85 M
|
-$7.31 M
|
-$915.46 K
|
-$1.69 M
|
-$733.69 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$838.00
|
$1.69 K
|
$1.63 K
|
$80.65 K
|
-$235.14 K
|
$0.00
|
| Net Income |
-$13.06 M
|
-$8.85 M
|
-$7.31 M
|
-$996.10 K
|
-$1.69 M
|
-$733.69 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.35 |
-0.25 |
-0.21 |
-0.17 |
-0.29 |
-0.0208 |
| EPS Diluted |
-0.35 |
-0.25 |
-0.21 |
-0.17 |
-0.29 |
-0.0208 |
| Weighted Average Shares Out |
$36.82 M
|
$36.68 M
|
$35.20 M
|
$5.76 M
|
$5.85 M
|
$35.20 M
|
| Weighted Average Shares Out Diluted |
$36.82 M
|
$36.68 M
|
$35.20 M
|
$5.76 M
|
$5.85 M
|
$35.20 M
|
| Link |
|
|
|
|
|
|
